Literature DB >> 18309965

Safety of very tight blood glucose control in type 2 diabetes.

Philip Home.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18309965      PMCID： PMC2258341          DOI： 10.1136/bmj.39499.514410.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones.

Authors:  D M Nathan; J B Buse; M B Davidson; E Ferrannini; R R Holman; R Sherwin; B Zinman
Journal:  Diabetologia       Date:  2008-01       Impact factor: 10.122

2.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Authors:  Anushka Patel; S MacMahon; J Chalmers; B Neal; M Woodward; L Billot; S Harrap; N Poulter; M Marre; M Cooper; P Glasziou; D E Grobbee; P Hamet; S Heller; L S Liu; G Mancia; C E Mogensen; C Y Pan; A Rodgers; B Williams
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

3.  Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.

Authors:  Rury R Holman; Kerensa I Thorne; Andrew J Farmer; Melanie J Davies; Joanne F Keenan; Sanjoy Paul; Jonathan C Levy
Journal:  N Engl J Med       Date:  2007-09-21       Impact factor: 91.245

4.  The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

Authors:  Matthew C Riddle; Julio Rosenstock; John Gerich
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

5.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

6.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

7.  Effect of a multifactorial intervention on mortality in type 2 diabetes.

Authors:  Peter Gaede; Henrik Lund-Andersen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245
  7 in total
  10 in total

Review 1.  Commentary: controversies in NICE guidance on management of type 2 diabetes.

Authors:  Stephen Atkin; Christopher Walton
Journal:  BMJ       Date:  2008-06-07

2.  Very tight glucose control: May be high risk, low benefit.

Authors:  John S Yudkin
Journal:  BMJ       Date:  2008-03-29

Review 3.  Different intensities of glycaemic control for pregnant women with pre-existing diabetes.

Authors:  Philippa Middleton; Caroline A Crowther; Lucy Simmonds
Journal:  Cochrane Database Syst Rev       Date:  2016-05-04

Review 4.  The changing role of the endocrinologist in the care of patients with diabetic retinopathy.

Authors:  Massimo Porta; Anna Viola Taulaigo
Journal:  Endocrine       Date:  2014-01-03       Impact factor: 3.633

Review 5.  Different intensities of glycaemic control for pregnant women with pre-existing diabetes.

Authors:  Philippa Middleton; Caroline A Crowther; Lucy Simmonds
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

6.  Effect of interactions between C peptide levels and insulin treatment on clinical outcomes among patients with type 2 diabetes mellitus.

Authors:  Gary T C Ko; Wing-Yee So; Peter C Tong; Wing-Bun Chan; Xilin Yang; Ronald C Ma; Alice P Kong; Risa Ozaki; Chun-Yip Yeung; Chun-Chung Chow; Juliana C Chan
Journal:  CMAJ       Date:  2009-04-28       Impact factor: 8.262

Review 7.  New drugs for type 2 diabetes mellitus: what is their place in therapy?

Authors:  Andrew J Krentz; Mayank B Patel; Clifford J Bailey
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up.

Authors:  Peter Bramlage; Anselm K Gitt; Steffen Schneider; Evelin Deeg; Diethelm Tschöpe
Journal:  BMC Cardiovasc Disord       Date:  2014-11-19       Impact factor: 2.298

9.  Hypoglycaemia, chronic kidney disease and death in type 2 diabetes: the Hong Kong diabetes registry.

Authors:  Alice P S Kong; Xilin Yang; Andrea Luk; Kitty K T Cheung; Ronald C W Ma; Wing Yee So; Chung Shun Ho; Michael H M Chan; Risa Ozaki; Chun Chung Chow; Nicola Brown; Juliana C N Chan
Journal:  BMC Endocr Disord       Date:  2014-06-13       Impact factor: 2.763

10.  Percussion Entropy Analysis of Synchronized ECG and PPG Signals as a Prognostic Indicator for Future Peripheral Neuropathy in Type 2 Diabetic Subjects.

Authors:  Hai-Cheng Wei; Na Ta; Wen-Rui Hu; Sheng-Ying Wang; Ming-Xia Xiao; Xiao-Jing Tang; Jian-Jung Chen; Hsien-Tsai Wu
Journal:  Diagnostics (Basel)       Date:  2020-01-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.